Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
FDA Advisors Recommend Expanding Triglyceride Drug Label
11/19/2019
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA recommended the approval of a drug to reduce the risk of cardiovascular events in high-risk patients.
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA recommended the approval of a drug to reduce the risk of cardiovascular events in high-risk patients.
The Endocrinologic and Metabolic...
11/19/2019
Pharmacy Learning Network

Advertisement

News
New Guidelines for Drug-Resistant TB Treatment
11/19/2019
The American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have developed new practice guidelines for the treatment of drug-resistant tuberculosis.
The American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have developed new practice guidelines for the treatment of drug-resistant tuberculosis.
The American Thoracic Society,...
11/19/2019
Pharmacy Learning Network
News
No Emerging Safety Concerns With 9-Valent HPV Vaccine
11/19/2019
"The results of this large safety study should reassure parents and patients; the 9vHPV vaccine is both safe and effective," said James Donahue, DVM, PhD, MPH, Marshfield Clinic Research Institute.
"The results of this large safety study should reassure parents and patients; the 9vHPV vaccine is both safe and effective," said James Donahue, DVM, PhD, MPH, Marshfield Clinic Research Institute.
"The results of this large...
11/19/2019
Pharmacy Learning Network
News
Anxiety Medication Recalled
11/15/2019
A Class II recall is active for a prescription benzodiazepine used to treat anxiety and panic disorders.
A Class II recall is active for a prescription benzodiazepine used to treat anxiety and panic disorders.
A Class II recall is active for...
11/15/2019
Pharmacy Learning Network

Advertisement

News
Antibiotic Recalled
11/15/2019
The FDA has issued a recall for a prescription antibiotic used to treat bacterial infections such as bronchitis, pneumonia, and tonsillitis.
The FDA has issued a recall for a prescription antibiotic used to treat bacterial infections such as bronchitis, pneumonia, and tonsillitis.
The FDA has issued a recall for...
11/15/2019
Pharmacy Learning Network
News
Recall Spans OTC, Prescription Antacids Sold Under Various Brands
11/14/2019
A recall is active for all over-the-counter and prescription ranitidine medications sold in the United States due to confirmed contamination with the probable carcinogen N-Nitrosodimethylamine.
A recall is active for all over-the-counter and prescription ranitidine medications sold in the United States due to confirmed contamination with the probable carcinogen N-Nitrosodimethylamine.
A recall is active for all...
11/14/2019
Pharmacy Learning Network
News
Severity of Flu Season, Shot Effectiveness Don`t Change Vaccination Rates
11/14/2019
Influenza-season severity and vaccine effectiveness do not appear to affect flu-vaccination rates in children, according to new research.
Influenza-season severity and vaccine effectiveness do not appear to affect flu-vaccination rates in children, according to new research.
Influenza-season severity and...
11/14/2019
Pharmacy Learning Network

Advertisement

News
Antibiotic-Resistant Infections Killing Twice as Many Americans as Once Thought
11/14/2019
Nearly twice as many people are dying in the United States from antibiotic-resistant infections than previously believed, US health officials recently said.
Nearly twice as many people are dying in the United States from antibiotic-resistant infections than previously believed, US health officials recently said.
Nearly twice as many people are...
11/14/2019
Pharmacy Learning Network
News
AHA, ACC Issue New Performance, Quality Measures for BP Management
11/14/2019
The American Heart Association and American College of Cardiology have released a report containing new clinical performance and quality measures for the diagnosis and treatment of hypertension in adults.
The American Heart Association and American College of Cardiology have released a report containing new clinical performance and quality measures for the diagnosis and treatment of hypertension in adults.
The American Heart Association...
11/14/2019
Pharmacy Learning Network
News
FDA Panel Votes Against Lilly-Boehringer Ingelheim`s Diabetes Drug
11/13/2019
Independent experts on an FDA advisory panel voted against the use of an already approved diabetes drug from Eli Lilly and Co and Boehringer Ingelheim as an add-on to insulin therapy in patients with type 1 diabetes.
Independent experts on an FDA advisory panel voted against the use of an already approved diabetes drug from Eli Lilly and Co and Boehringer Ingelheim as an add-on to insulin therapy in patients with type 1 diabetes.
Independent experts on an FDA...
11/13/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use